FDA Approved: GLATIRAMER ACETATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for glatiramer acetate by Mylan Pharmaceuticals, authorizing a generic version of the therapy for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)